Results 11 to 20 of about 6,201 (191)
Remission of giant lymph node hyperplasia with anemia after radiotherapy [PDF]
Cancer, 1979 We have described a 51-year-old patient with unresectable mesenteric giant lymph node hyperplasia of the plasma cell type, severe systemic manifestations, and profound anemia. Supression of erythropoiesis may have been related to the presence of a circulating erythropoietic inhibitor produced by the lymphoid tumor.
D D, Weisenburger +3 more
openaire +3 more sources
Radiation therapy in the management of giant lymph node hyperplasia
The British Journal of Radiology, 1990 The response of giant lymph node hyperplasia (Castleman's disease) to surgery is well known and surgery is the main technique in the management of these patients. We describe a young man who presented with clinical features suggestive of a lymphoma, but who was diagnosed to have Castleman's disease after histopathology.
T, Sethi +3 more
openaire +3 more sources
Giant lymph node hyperplasia: Persistence of symptoms for 15 years [PDF]
Cancer, 1982 A woman with giant lymph node hyperplasia of the mediastinum and systemic symptoms was treated with radiotherapy. Following a short partial remission, symptoms have persisted for 15 years. Surgical excision remains the treatment of choice, although the failure of radiotherapy may be due to inadequate dosage.
D H, Moir, T, Choy, W R, Dalton
openaire +3 more sources
Giant lymph node hyperplasia (Castleman's disease) of the mesentery
Gastroenterology, 1984 Ingvar Bjarnason +5 more
openaire +2 more sources
A case of Paraneoplastic Pemphigus associated with Castleman's disease [PDF]
Anais Brasileiros de Dermatologia, 2013 We present a case of PNP associated with Castleman's Disease. We have also reviewed the literature and described the characteristics of the two associated diseases. Gene clonal rearrangement was done to help diagnosis.
Meihua Zeng +5 more
doaj +1 more source
Castleman’s Disease Presenting as an Abdominal Mass [PDF]
International Journal of Anatomy Radiology and Surgery, 2016 Castleman’s disease is an uncommon lymphoproliferative disorder. It can present as unicentric disease or multicentric disease. Here we present a case in which a 60 year old female who presented with upper abdominal discomfort was evaluated with ...
C. Valiathan Gopakumar +2 more
doaj +1 more source
Zaporožskij Medicinskij Žurnal, 2022 Castleman’s disease (angiofollicular lymphoma, giant lymph node hyperplasia, Castleman’s pseudotumor) is an understudied orphan lymphoproliferative disease with a long period of asymptomatic course and a high risk of malignancy, and variability of its ...
V. I. Tsumbaliuk +6 more
doaj +1 more source
Incidentally detected Castleman disease in a patient with allergic rhinosinu sitis [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2008 INTRODUCTION Castleman disease was for the first time described in 1956 as a mediastinal tumour mass. Etiology of this disease is still unknown. The disease can be solitary and multicentric or rarely of a mixed type.
Stojšić Jelena +4 more
doaj +1 more source
Zaporožskij Medicinskij Žurnal, 2022 Castleman’s disease (angiofollicular lymphoma, giant lymph node hyperplasia, Castleman’s pseudotumor) is an understudied orphan lymphoproliferative disease with a long period of asymptomatic course and a high risk of malignancy, and variability of its ...
O. M. Mukvich +5 more
doaj +1 more source
Unicentric Castlemans Disease: Unusual Disorder of the Neck a Case Review [PDF]
Journal of Clinical and Diagnostic Research, 2015 Castleman’s disease (giant or angio follicular lymph node hyperplasia) was first described by Benjamin Castleman in the year 1957 and was named after him. It is an uncommon lympho proliferative disorder which is localised to single lymphnode (unicentric)
Renuka S. Melkundi +4 more
doaj +1 more source